Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit

InjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the payment of $1 million into third-party escrow account. Closing on the Asset Purchase and the Syringe Sales Agreement, for product orders totaling over$200 million for the first five years of operation, is expected within the next 60 days. Based on the most likely timeframe, product shipments from the SC facility are planned to begin by Q2 of 2025. NEW YORK, June 05, 2024 (GLOBE NE ...